Vanberra Signal

Freenome

Curated by Signal

Provider of a deep learning platform for detecting circulating cancer-related markers

Overview

Provider of a deep learning platform for detecting circulating cancer-related markers. It offers a platform for detecting circulating cancer-related markers in patient blood samples. Its proprietary technology uses deep learning to detect cell-free DNA, immune cell fragments, and metabolic markers in the blood. It allows physicians to classify tumor types and develop treatment therapies for prostate, breast, colorectal, and lung cancer.

Key facts

Founded
2014
Headquarters
United States

Business model

Contact

Open roles

55 roles
  • Inventory Specialist I (Contractor)

    Brisbane, CA · On-site · Volunteer

  • Quality Control Specialist I (Contractor)

    Brisbane, CA · On-site · Volunteer

  • Clinical Laboratory Associate I (Contractor)

    Brisbane, CA · On-site · Volunteer

+ 52 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Information engine for clinical decision support and personalized care plans

    Life Sciences TechnologyHoboken, United States
  • Developer of visualization system for surgeries

    Life Sciences TechnologySeattle, United States
  • Developer of smart devices for treating pulmonary diseases

    Life Sciences TechnologyRedwood City, United States

About Freenome

What does Freenome do?

Provider of a deep learning platform for detecting circulating cancer-related markers.

Where is Freenome headquartered?

Freenome is headquartered in United States.

When was Freenome founded?

Freenome was founded in 2014.

Which sector is Freenome in?

Freenome operates in Life Sciences Technology.

Who are Freenome's competitors?

Companies similar to Freenome include HALE life, Proprio, and Pulmonx.

Is Freenome hiring?

Yes. Freenome has 55 open roles listed on Vanberra Signal.